Citation Impact
Citing Papers
Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma
2007 Standout
Satb1 regulates the effector program of encephalitogenic tissue Th17 cells in chronic inflammation
2019 StandoutNobel
Bone Marrow Histopathologic and Molecular Staging in Epidermotropic T-Cell Lymphomas
2003
Multicenter Photopheresis Intervention Trial in Early-Stage Mycosis Fungoides
2011
EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome
2006
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
High Clinical Response Rate of S ézary Syndrome to Immunomodulatory Therapies
2011
Role of AID in Tumorigenesis
2007 StandoutNobel
Sézary cell counts in erythrodermic cutaneous T-cell lymphoma: Implications for prognosis and staging
2006
U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease
2008
Arrestin Development: Emerging Roles for β-arrestins in Developmental Signaling Pathways
2009 StandoutNobel
Epidemiology of Prostate Cancer
2019 Standout
Prognostic factors and prediction of prognosis by the CTCL Severity Index in mycosis fungoides and Sezary syndrome
2005
Mycosis Fungoides and Sezary Syndrome
2017
Photopheresis in the treatment of cutaneous T-cell lymphoma
2011
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
Sézary syndrome: Immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC)
2010
Public Engagement as a Means of Restoring Public Trust in Science – Hitting the Notes, but Missing the Music?
2006 Standout
Extracorporeal Photopheresis in the Treatment of Mycosis Fungoides and Sézary Syndrome
2015
Insulin and insulin-like growth factor signalling in neoplasia
2008 Standout
Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group
2005
Long-term Outcome of 525 Patients With Mycosis Fungoides and Sézary Syndrome
2003
Medical History, Lifestyle, Family History, and Occupational Risk Factors for Mycosis Fungoides and Sezary Syndrome: The InterLymph Non-Hodgkin Lymphoma Subtypes Project
2014
Targeting apoptosis in cancer therapy
2020 Standout
Graft-versus-host disease
2009 Standout
European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2017
2017
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
2010 Standout
Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome
2018 Nature
Update on erythrodermic cutaneous T-cell lymphoma: Report of the international society for cutaneous lymphomas
2002
Severe Adverse Cutaneous Reactions to Drugs
1994 Standout
CAR-T cell therapy: current limitations and potential strategies
2021 Standout
Extracorporeal photopheresis for the treatment of Sézary syndrome using a novel treatment protocol
2008
Extracorporeal Photopheresis for Acute and Chronic Graft-versus-Host Disease: Does It Work?
2006
The AID Dilemma
2012 StandoutNobel
The Sézary syndrome: hematologic criteria
2003
Peripheral Blood T-Cell Clonality in Mycosis Fungoides and Nonlymphoma Controls
2003
Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides
2006
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
2009 Standout
Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)
2006 Standout
Cyborg Urbanization: Complexity and Monstrosity in the Contemporary City
2005 Standout
Erythroderma and its management*
1982
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
On Acting and Knowing: How Pragmatism Can Advance International Relations Research and Methodology
2009 Standout
2016 US lymphoid malignancy statistics by World Health Organization subtypes
2016 Standout
Social Emergence
2005
The Type 1 Insulin-Like Growth Factor Receptor Pathway
2008
Containing the Atom: Sociotechnical Imaginaries and Nuclear Power in the United States and South Korea
2009 Standout
Reiter's Syndrome and Reactive Arthritis in Perspective
1983
Diabetes and Cancer
2010 Standout
Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sezary syndrome
2003
Profound loss of T-cell receptor repertoire complexity in cutaneous T-cell lymphoma
2003
De-Westernizing communication/social science research: opportunities and limitations
2010 Standout
SATB1 Defines a Subtype of Cutaneous CD30+ Lymphoproliferative Disorders Associated with a T-Helper 17 Cytokine Profile
2018
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Molecular biology of microbial ureases
1995 Standout
Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response
2003
Multi-Agent Systems for the Simulation of Land-Use and Land-Cover Change: A Review
2003 Standout
Social-ecological systems as complex adaptive systems: organizing principles for advancing research methods and approaches
2018 Standout
BET inhibition in advanced cutaneous T cell lymphoma is synergistically potentiated by BCL2 inhibition or HDAC inhibition
2018
CutaneousT ‐cell lymphoma: 2016 update on diagnosis, risk‐stratification, and management
2015
Coordination in Large Numbers: An Agent-Based Model of International Negotiations
2008
Diagnosing erythrodermic cutaneous T-cell lymphoma
2005
Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD
2005
Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
2008 Standout
Cultural Pragmatics: Social Performance between Ritual and Strategy
2004 Standout
A retrospective comparative outcome analysis following systemic therapy in M ycosis fungoides and S ezary syndrome
2016
How I treat mycosis fungoides and Sézary syndrome
2016
Contextualizing Entrepreneurship—Conceptual Challenges and Ways Forward
2011 Standout
Extracorporeal photopheresis for the treatment of early-stage mycosis fungoides
2017
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
2009 StandoutScience
Chains and networks, territories and scales: towards a relational framework for analysing the global economy
2001 Standout
Systemic therapy for cutaneous T-cell lymphoma: who, when, what, and why?
2016
Reflexing Complexity
2005
The Place of Complexity
1999
A Postcapitalist Politics
2006 Standout
Phase space: geography, relational thinking, and beyond
2009 Standout
Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
2007 Standout
The role of extracorporeal photopheresis in the management of cutaneous T‐cell lymphoma, graft‐versus‐host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society
2017
Works of Alan Dean being referenced
Diagnostic and prognostic importance of T-cell receptor gene analysis in patients with S�zary syndrome
2001
Extracorporeal photopheresis in Sezary syndrome: hematologic parameters as predictors of response
2001
Characterization of NSCLC patients responding to anti-IGF-IR therapy
2008
An evaluation of the Coulter Counter Model T660
1987
The absence of Sezary cells in the peripheral blood of patients with generalized inflammatory dermatoses
1980
Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma
2001
T AND B LYMPHOCYTES IN PATIENTS WITH ACUTE ANTERIOR UVEITIS AND ANKYLOSING SPONDYLITIS, AND IN THEIR HOUSEHOLD CONTACTS
1979
Chaos, Complexity and Sociology: Myths, Models and Theories
1998
Survival Outcomes and Prognostic Factors in Mycosis Fungoides/Sézary Syndrome: Validation of the Revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer Staging Proposal
2010